Abamune-L Tablet (Abacavir 600mg + Lamivudine 300mg)
Manufacturer: Cipla Ltd
Composition: Abacavir 600mg + Lamivudine 300mg
Dosage Form: Oral Tablet
Therapeutic Class: Antiretroviral Agent
Product Overview
Abamune-L Tablet is a prescription antiretroviral medication used in the management of HIV-1 infection. It combines two active ingredients—Abacavir (600mg) and Lamivudine (300mg)—both belonging to the class of nucleoside reverse transcriptase inhibitors (NRTIs). This fixed-dose combination works synergistically to inhibit the replication of the HIV virus, thereby reducing the viral load and improving immune function.
By controlling viral replication, Abamune-L Tablet helps delay the progression of HIV infection to AIDS (Acquired Immunodeficiency Syndrome) and reduces the risk of HIV-related complications. It is an essential part of Highly Active Antiretroviral Therapy (HAART) for long-term viral suppression.
@ERNESTPHARMACEUTICALPVTLTD
For bulk quotations, availability, and orders, please contact us:
📧 Email: exports@ernestpharmaceuticals.com
🌐 www.ernestpharmaceuticals.com| www.ernestimpex.com
Amit Rai: WhatsApp link https://wa.me/message/M6GESWXSIOZMD1
📲 WhatsApp: +91 94054 76170
Mechanism of Action
Both Abacavir and Lamivudine act by inhibiting the reverse transcriptase enzyme, which is critical for viral RNA to convert into DNA—a key step in HIV replication. By blocking this enzyme, Abamune-L Tablet prevents the virus from multiplying, allowing the immune system to recover and function more effectively.
Indications
Treatment of HIV-1 infection in adults and adolescents (above 18 years)
Used as part of a combination antiretroviral regimen
Helps in reducing the risk of HIV transmission when combined with safe sex practices and adherence to therapy
Dosage and Administration
Route of Administration: Oral
Dosage: As prescribed by a healthcare professional
Instructions:
Take the tablet once daily, with or without food.
Swallow whole with water; do not crush or chew.
Maintain regular dosing intervals for optimal effectiveness.
Safety Information
Contraindications: Known hypersensitivity to Abacavir, Lamivudine, or any excipients in the formulation.
Pregnancy & Lactation: Consult a physician before use. Breastfeeding is generally not recommended in HIV-positive mothers.
Alcohol: Avoid alcohol consumption as it may increase the risk of liver toxicity.
Driving: Use caution; the medicine may cause dizziness or fatigue in some individuals.
Side Effects
Common side effects include:
Headache
Nausea or diarrhea
Fatigue
Rash
Dizziness
Fever
Most effects are mild and temporary. Seek medical attention if severe allergic reactions or persistent symptoms occur.
Storage Instructions
Store in a cool, dry place below 30°C (86°F).
Protect from direct sunlight and moisture.
Keep out of reach of children.
Non-cold chain product — no refrigeration required.
Key Benefits
Dual-action formulation targeting HIV replication
Reduces viral load and strengthens immune response
Delays the onset of AIDS and HIV-related complications
Helps lower the risk of HIV transmission when taken consistently
Manufacturer: Cipla Ltd
Composition: Abacavir 600mg + Lamivudine 300mg
Dosage Form: Oral Tablet
Therapeutic Class: Antiretroviral Agent
Product Overview
Abamune-L Tablet is a prescription antiretroviral medication used in the management of HIV-1 infection. It combines two active ingredients—Abacavir (600mg) and Lamivudine (300mg)—both belonging to the class of nucleoside reverse transcriptase inhibitors (NRTIs). This fixed-dose combination works synergistically to inhibit the replication of the HIV virus, thereby reducing the viral load and improving immune function.
By controlling viral replication, Abamune-L Tablet helps delay the progression of HIV infection to AIDS (Acquired Immunodeficiency Syndrome) and reduces the risk of HIV-related complications. It is an essential part of Highly Active Antiretroviral Therapy (HAART) for long-term viral suppression.
@ERNESTPHARMACEUTICALPVTLTD
For bulk quotations, availability, and orders, please contact us:
📧 Email: exports@ernestpharmaceuticals.com
🌐 www.ernestpharmaceuticals.com| www.ernestimpex.com
Amit Rai: WhatsApp link https://wa.me/message/M6GESWXSIOZMD1
📲 WhatsApp: +91 94054 76170
Mechanism of Action
Both Abacavir and Lamivudine act by inhibiting the reverse transcriptase enzyme, which is critical for viral RNA to convert into DNA—a key step in HIV replication. By blocking this enzyme, Abamune-L Tablet prevents the virus from multiplying, allowing the immune system to recover and function more effectively.
Indications
Treatment of HIV-1 infection in adults and adolescents (above 18 years)
Used as part of a combination antiretroviral regimen
Helps in reducing the risk of HIV transmission when combined with safe sex practices and adherence to therapy
Dosage and Administration
Route of Administration: Oral
Dosage: As prescribed by a healthcare professional
Instructions:
Take the tablet once daily, with or without food.
Swallow whole with water; do not crush or chew.
Maintain regular dosing intervals for optimal effectiveness.
Safety Information
Contraindications: Known hypersensitivity to Abacavir, Lamivudine, or any excipients in the formulation.
Pregnancy & Lactation: Consult a physician before use. Breastfeeding is generally not recommended in HIV-positive mothers.
Alcohol: Avoid alcohol consumption as it may increase the risk of liver toxicity.
Driving: Use caution; the medicine may cause dizziness or fatigue in some individuals.
Side Effects
Common side effects include:
Headache
Nausea or diarrhea
Fatigue
Rash
Dizziness
Fever
Most effects are mild and temporary. Seek medical attention if severe allergic reactions or persistent symptoms occur.
Storage Instructions
Store in a cool, dry place below 30°C (86°F).
Protect from direct sunlight and moisture.
Keep out of reach of children.
Non-cold chain product — no refrigeration required.
Key Benefits
Dual-action formulation targeting HIV replication
Reduces viral load and strengthens immune response
Delays the onset of AIDS and HIV-related complications
Helps lower the risk of HIV transmission when taken consistently
Keywords
